OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
FRTX-02, a selective and potent inhibitor of DYRK1A, modulates inflammatory pathways in mouse models of psoriasis and atopic dermatitis
Soochan Kim, Eunhwa Ko, Hwan Geun Choi, et al.
Journal of Translational Autoimmunity (2022) Vol. 6, pp. 100185-100185
Open Access | Times Cited: 6
Soochan Kim, Eunhwa Ko, Hwan Geun Choi, et al.
Journal of Translational Autoimmunity (2022) Vol. 6, pp. 100185-100185
Open Access | Times Cited: 6
Showing 6 citing articles:
Discovery of ZJCK-6-46: A Potent, Selective, and Orally Available Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor for the Treatment of Alzheimer’s Disease
Huanhua Chen, Xudong Gao, Xinzhu Li, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 15, pp. 12571-12600
Closed Access | Times Cited: 6
Huanhua Chen, Xudong Gao, Xinzhu Li, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 15, pp. 12571-12600
Closed Access | Times Cited: 6
DYRK1A-TGF-β signaling axis determines sensitivity to OXPHOS inhibition in hepatocellular carcinoma
Ying Cao, Ruolan Qian, Ruiqin Yao, et al.
Developmental Cell (2025)
Closed Access
Ying Cao, Ruolan Qian, Ruiqin Yao, et al.
Developmental Cell (2025)
Closed Access
DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibition
V.S.S. Abhinav Ayyadevara, Gerald Wertheim, Shikha Gaur, et al.
Leukemia (2025)
Open Access
V.S.S. Abhinav Ayyadevara, Gerald Wertheim, Shikha Gaur, et al.
Leukemia (2025)
Open Access
Eriodictyol inhibits the proliferation and inflammatory response in keratinocytes in psoriasis through inactivating DYRK1A-mediated endoplasmic reticulum stress
Yuan Rui, Qi-Chao Sun, Yuepeng An, et al.
Journal of Asian Natural Products Research (2025), pp. 1-13
Closed Access
Yuan Rui, Qi-Chao Sun, Yuepeng An, et al.
Journal of Asian Natural Products Research (2025), pp. 1-13
Closed Access
Discovery and Functional Characterization of a Potent, Selective, and Metabolically Stable PROTAC of the Protein Kinases DYRK1A and DYRK1B
Gerrit Wilms, Kevin Schofield, Shayna Maddern, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 2
Gerrit Wilms, Kevin Schofield, Shayna Maddern, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 2
Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer’s Disease and Down Syndrome
Laurent Meijer, Emilie Chrétien, Denis Ravel
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S95-S113
Closed Access | Times Cited: 2
Laurent Meijer, Emilie Chrétien, Denis Ravel
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S95-S113
Closed Access | Times Cited: 2
